Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

Figure 8

Molecular models of active compounds binding to the predicted targets. (a) CASP3 and kaempferol; (b) HIF-1 and quercetin; (c) ESR1 and isorhamnetin; (d) ESR1 and ent-Epicatechin.

(a)

(b)

(c)

(d)